Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Endovasc submits protocol for phase III Liprostin trial
Intermittent claudication occurs when the arteries that supply blood to the legs become clogged with fatty deposits. This painful condition includes aches or cramps in the calf, buttock,
Intermittent claudication occurs when the arteries that supply blood to the legs become clogged with fatty deposits. This painful condition includes aches or cramps in the calf, buttock,
The main objective of these studies is to evaluate the efficacy of Technosphere Insulin (TI) by assessing changes both in HbA1c levels as well as in blood glucose
Data showing safety and statistical significance relative to the efficacy endpoints in the study were presented at the 2006 annual meeting of the American Academy of Allergy, Asthma
Under the terms of the agreement, Bharat Biotech International (BBIL) will fund 100% of the preclinical and clinical studies for these south Asian markets and assist in developing
Valortim (MDX-1303) is an investigational fully human antibody created using Medarex’ UltiMAb human antibody development system that targets the Bacillus anthracis protective antigen. The investigational antibody is designed
Even after controlling for such factors as age, degree of heart disease and severity of depression, the Duke University Medical Center researchers found that heart patients taking antidepressant
An advert released by P&G claimed that four out five dentists would recommend its Crest Pro Health mouthwash, however Pfizer has alleged that the advertising was false and
Vicriviroc is an investigational CCR5 receptor antagonist currently being evaluated by the NIH-sponsored Adult AIDS Clinical Trials Group (ACTG) in an ongoing phase II clinical study of 118
Dr Reddy’s produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with a particular focus on India, US, Europe and Russia. The company
The company chose to withdraw the application for Retaane 30mg/ml (anecortave acetate suspension for depot injection) after being informed by the EMEA that it would have to provide